Integra LifeSciences | IART - Current Liabilities

Stock Price
12.21
Daily Change
0.16 1.33%
Monthly
0.16%
Yearly
-42.21%
Q1 Forecast
11.83

Integra LifeSciences reported $364.05M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
AtriCure USD 81.52M 3.68M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
CONMED USD 315.04M 342K Dec/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Globus Medical USD 465.96M 41.29M Sep/2025
HeartBeam USD 2.47M 671K Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Medtronic USD 9.94B 1.6B Sep/2025
Merit Medical Systems USD 230.48M 4.9M Sep/2025
Orthofix International USD 159.85M 11.47M Sep/2025
Smith & Nephew USD 1.54B 236M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 773.03M 56.88M Sep/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025